These findings agree with previous studies (Hasegawa et al., 1997 and Hasegawa et al., 2000) showing that CV treatment increased mRNA levels for granulocyte–macrophage colony-stimulating factor (GM-CSF). This stimulus can be attributed to the presence of a glycoprotein, which is purified from CV, is soluble in water and has been reported

to be a hematopoietic stimulator that increases CSF levels and promotes progenitor cell migration from the bone marrow to the spleen followed by an expansion GW-572016 order of CFU-GM in this organ after chemotherapy (Konishi et al., 1996). The presence of α-tocopherol in CV, the former of which is a member of the vitamin E family and possesses numerous biological properties including significant effects on inflammation, cell proliferation, and apoptosis (Azzi, 2007, Lemaire-Ewing et al., 2010 and Singh et al., 2006), may also be important here, as it has been shown to increase the number of HP as demonstrated by CFU-GM assays in the bone marrow of irradiated mice after treatment (Bichay and Roy, 1986, Cherdyntseva et al., 2005 and Roy et al., 1982). The presence of these components in CV can explain, in part, the fact that we observed a small but significant increase in CSA in the BM of non-stressed animals after CV treatment; however, this increase Selleck BTK inhibitor did not interfere with the number of HP or with the CFU-GM. The reduced capacity of cultured cells to support the growth and differentiation of CFU-GM following

the application of SST or RST was consistent throughout the duration of the cultures (7 weeks), and the suppression caused by SST was more severe until the 7th week. From the 1st to the 4th weeks of culture, the stromal layer is formed in the flasks. In the 5th week, the cultures are repopulated with cells from the respective groups of mice. These cells interact with the stroma, demonstrating their capability to maintain hematopoiesis. Therefore, we propose that SST and RST directly interfere with the physical contacts between stromal and hematopoietic cells. This hypothesis is in agreement with a significant reduction in the

local 3-oxoacyl-(acyl-carrier-protein) reductase production of IL-6 and IL-1α by stromal cells after stressor application, as observed in this study. IL-6 plays a critical role in the generation and maintenance of myelopoiesis in murine LTBMC (Hauser et al., 1997) and is a survival factor for hematopoietic stem cells (Bernard et al., 1994). Both IL-6 and IL-1α have synergistic activity with CSFs in stimulating hematopoiesis, thus contributing to the maintenance of neutrophil maturation and viability (Eaves et al., 1991, Dinarello, 1996 and Muench et al., 1992). Studies in the literature demonstrate that IL-1α accelerates both granulopoietic and thrombopoietic recovery in 5-fluorouracil myelosuppressed mice (Kovacs et al., 1997). However, in contrast to what we observed with HP and CFU-GM numbers, the decrease caused by SST and RST on the levels of these cytokines was of equal magnitude.